Publicaciones
-
San L, Arranz B and Martinez-Raga J.
Antipsychotic drug treatment of schizophrenic patients with substance abuse disorders
EUROPEAN ADDICTION RESEARCH . 13(4): 230-243. Nº de citas: 26
-
San L, Arranz B, Querejeta I, Barrio S, De la Gándara J and Pérez V.
A naturalistic multicenter study of intramuscular olanzapine in the treatment of acutely agitated manic or schizophrenic patients
EUROPEAN PSYCHIATRY . 21(8): 539-543. Nº de citas: 36
-
Reynolds GP, Arranz B, Templeman LA, Fertuzinhos S and San L.
Effect of 5-HT1A receptor gene polymorphism on negative and depressive symptom response to antipsychotic treatment of drug-naive psychotic patients
AMERICAN JOURNAL OF PSYCHIATRY . 163(10): 1826-1. Nº de citas: 86
-
San L and Arranz B.
Mirtazapine: only for depression?
Acta Neuropsychiatrica . 18(3-4): 130-143. Nº de citas: 11
-
Ramirez N, Arranz B, Sanchez JM, Centeno M and San L.
Depression in schizophrenia, can it be treated? A review of the evidence
Current Psychiatry Reviews . 2(3): 371-379. Nº de citas: 2
-
Sanchez, JM, Montejo, AL, Mensa, I, Ramirez, N, Arranz B and Centeno, M.
Quality of life in insulin-treated diabetic out-patients
EUROPEAN NEUROPSYCHOPHARMACOLOGY . 15(3): 396-396.
-
Reynolds, GP, Templeman, LA, Arranz B, San L and Zhang, ZJ.
5-HT receptor genes and antipsychotic drug effects
NORDIC JOURNAL OF PSYCHIATRY . 59(5): 397-397.
-
Templeman LA, Reynolds GP, Arranz B and San L.
Polymorphisms of the 5-HT2C receptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosis.
Pharmacogenetics and Genomics . 15(4): 195-200. Nº de citas: 204
-
San L, Arranz B, Duenas, P, de la Gandara, J and Perez, V.
Intramuscular olanzapine in acutely agitated manic or schizophrenic patients. A naturalistic study
EUROPEAN PSYCHIATRY . 20(1): 66-66.
-
San L, Arranz B and Escobar R.
Pharmacological management of acutely agitated schizophrenic patients
CURRENT PHARMACEUTICAL DESIGN . 11(19): 2471-2477. Nº de citas: 5
